Skip to content

IONS

Ionis Pharmaceuticals, Inc.

Stock

$43.54−0.46 (−1.05%)Close Oct 2, 2026

Key figures

MetricLast 12 months5-year CAGR
Revenue$874M+5.3%
Gross profit$858M+5.3%
Operating income−$594M—
Net income−$565M—
EPS−$3.70—
Free cash flow−$561M—